Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...

While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Vertex's lineup will look transformed in five years, and the company should continue performing well beyond that time. It's ...

However, its low valuation could have investors wondering if now is the right time to take a chance on the business, ...

Stocks started the week lower, pulled downward by investors' worries about the health of the AI trade. Under the hood of the ...

Generally, you can count on drugmakers for a steady revenue performance -- since patients need their medicines, revenue holds ...

Healthcare stocks can be a great investment. Stocks in the healthcare sector, which are holistically represented by the Health Care Select Sector SPDR ETF (XLV), have broadly outperformed the ...

For its most recently reported quarter (Q3 of 2024), Hims & Hers generated $401.6 million in revenue. That resulted in a free ...

Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Scilex Holding Company (SCLX – Research Report) ...